Joint statement on Savvy Phase 3 trial in Ghana to test the effectiveness of Savvy Gel in preventing HIV

Research Triangle Park, NC and Huntingdon Valley, PA -- International efforts are underway to evaluate microbicides as a tool to prevent HIV infection in people at high risk. As part of this initiative, with funding from the U.S. Agency for International Development (USAID), Family Health International (FHI) and Cellegy Pharmaceuticals, Inc. have been working to see if a vaginal gel called Savvy is effective in preventing male-to-female transmission of HIV among women at high risk of infection in West Africa. Other organizations are conducting trials in the United States to determine if Savvy is effective as a contraceptive.

Family Health International and Cellegy Pharmaceuticals announced today that they plan to stop the HIV prevention trial of Savvy being conducted by FHI in Ghana. This decision followed a recommendation of the study's external, independent Data Monitoring Committee (DMC). The DMC reviewed the study data to date and concluded that, while there is no evidence of safety concerns based on the comparative HIV infection rates in the Savvy and placebo groups, the Ghana study would be unable to evaluate the effectiveness of the product.

The Savvy Phase 3 clinical trial in Ghana began recruitment in March 2004 and completed planned enrollment with 2,142 women in June 2005. Half of the women were given Savvy gel, and half were given a placebo gel to be inserted vaginally with pre-filled applicators. At monthly visits during each woman's year-long follow-up, each participant was tested for HIV and reported on use of the gel and any side effects or medical problems. Each participant received counseling for reducing her risk of HIV and was given condoms for use during all sexual acts. Eighteen months into the study, the observed HIV incidence in the cohort was about one-third the rate expected prior to the study.

"The reason we decided to stop the trial was that the group of women who volunteered to participate had such a low inciden

Contact: Beth Robinson
Rational PR

Page: 1 2 3

Related medicine news :

1. Joint Principles of PC-MH released by organizations representing more than 300,000 physicians
2. AHA statement recommends doctors change approach
3. CHPA statement regarding Monitoring the Future findings on cough medicine abuse
4. International AIDS Vaccine Initiative statement on male circumcision
5. AASM position statement: Treating insomnia with over-the-counter sleep aids, herbal supplements
6. American Thoracic Society publishes new statement on hepatotoxicity of antituberculosis therapy
7. NHLBI and NIH statements on totally implanted permanent artificial heart
8. ESC statement on the CHARISMA trial on Clopidogrel (Plavix)
9. ESC issues policy statement on reperfusion therapy
10. American Dietetic Association statement on new MyPyramid
11. GSK announces launch of largest ever Phase III trial in lung cancer treatment

Post Your Comments:

(Date:4/19/2019)... ... April 19, 2019 , ... AXIOM Implant ... prosthetic implant dentistry, will host a free dental implant seminar at their office ... valuable information related to dental implants, including; procedure explanation, health and lifestyle benefits, ...
(Date:4/19/2019)... ... 2019 , ... Elohi Strategic Advisors is proud to introduce ... plant-based proteins to herbal tonics, gluten-free pastas to Keto-friendly sweeteners, these brands represent ... • Field Roast, a Seattle-based company, is the original maker of grain meats. ...
(Date:4/18/2019)... ... April 18, 2019 , ... Swiss Pet company PerAnimal launches ... support the bond between human and animal while improving the overall wellness of pet ... specialists with decades of experience. They are made by hand from organic Swiss herbal ...
(Date:4/18/2019)... ... April 18, 2019 , ... She went from learning disabled to ... said her mother, Cheryl Reilly. Those “goofy tests,” performed by Deborah Zelinsky, O.D. ... 12 years old, had such narrow range of visual awareness, she could only see ...
(Date:4/17/2019)... ... April 17, 2019 , ... With Fentanyl overdose deaths continuing to claim lives ... death toll by looking for an alternative to naloxone. Researchers are presenting their ... week. , Naloxone (often known by the name brand Narcan) has been utilized increasingly ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... FindaTopDoc is proud to announce ... of the country’s premier professional associations dedicated to the service and assistance of ... represents over 25,000 members on issues of legislation and regulatory affairs, medical economics ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... by Sleep Outfitters and Tempur Sealy, at Fasig-Tipton horse farm on May 17, ... Located in the heart of the Bluegrass, this elegant venue highlights Kentucky's stunning ...
(Date:4/17/2019)... , ... April 18, 2019 , ... End of Life Disconnect: “9/10 people say they ... hospital or some other institution.” -NHPCO Gallup Poll 1996 , On April 20th the very ... Life Doula Training will be offered in 26 locations, in 5 countries and in ...
Breaking Medicine Technology:
Cached News: